SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NEXTEL -- Ignore unavailable to you. Want to Upgrade?


To: Ed Pittman who wrote (3455)12/5/1997 5:25:00 PM
From: Ken Benes  Read Replies (1) | Respond to of 10227
 
Ed:

I don't know if you saw the note over on the bema thread about a website with an essay on the Rothchilds and their ability to control markets. Frankly, after the selloff in October and the damage to the Asian markets, I thought a return to old highs so soon was a remote possibility. I guess it was not so remote. I would read the article because it is not out of the realm of possibility that the smashing of the Asian currencies was done with the distinct purpose of cooling world growth to a level that would not ignite inflation. If this is in fact accomplished and the US continues on a 2 -3% growth rate, with the other emerging markets in South America, Europe(old communist countries), and Africa remaining in a growth mode, the markets may indeed continue to advance.
With todays employment numbers and the economic activity I see in New York, and the surrounding states, it appears to me that Asia may have a limited impact on our economy and may promote a very low rate of inflation with interest rates that may break 6%. Not a great scenario for those over at bgo, but a great scenario for nxtl.

While watching the action today, it definitely occurred to me that should 23.5 not hold and the price decline to below the low in October of 22.5, this stock could be in serious trouble. I was able to keep my perspective by reflecting on the fundamentals so eloquently stated by Arnie and the proceeds of my own research. Next week can be somewhat critical for nxtl unless it stagnates in a new lower trading range. I believe the stock will begin to move long before a positive news release is put out by the company. There are too many astute people out there who have a way of finding out positive information prior to its public release and consequently are always ahead of the crowd.
This is a scenario playing out with ICOS, a biotech that is awaiting imminent approval on some block buster drugs. ICOS is headed by a guy named Rathmann who founded Amgen and is considered by many to be a genius. The drugs awaiting approval may be equal to Amgen's neuprogen and epogen.

Ken